Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 20.98
-0.08 (-0.38%)
Feb 13, 2026, 3:09 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 12.48 billion as of February 13, 2026. Its market cap has increased by 23.63% in one year.
Market Cap
12.48B
Enterprise Value
9.41B
Revenue
976.44M
Ranking
n/a
PE Ratio
177.16
Stock Price
20.98
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 12.48B, a decrease of -55.61%. That is a compound annual growth rate of -18.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 12.48B | 12.61% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 14.17B |
| InventisBio | 13.55B |
| Staidson (Beijing) BioPharmaceuticals | 13.14B |
| Pacific Shuanglin Bio-pharmacy | 13.06B |
| Beijing Hotgen Biotech | 12.47B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.00B |
| HitGen | 11.92B |
| Vcanbio Cell & Gene Engineering Corp., | 11.78B |